Sutro Biopharma (STRO) Net Margin Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Net Margin Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 680.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -21,924.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21,924.00 |
| Sep 30, 2025 | -1,396.00 |
| Jun 30, 2025 | 16,876.00 |
| Mar 31, 2025 | 5,885.00 |
| Dec 31, 2024 | -51,649.00 |
| Sep 30, 2024 | -28,141.00 |
| Jun 30, 2024 | 18,320.00 |
| Mar 31, 2024 | -5,261.00 |
| Dec 31, 2023 | 42,807.00 |
| Sep 30, 2023 | -21,371.00 |
| Jun 30, 2023 | -27,741.00 |
| Mar 31, 2023 | 26,832.00 |
| Dec 31, 2022 | -4,292.00 |
| Sep 30, 2022 | 28,533.00 |
| Jun 30, 2022 | -7,065.00 |
| Mar 31, 2022 | -52,904.00 |
| Dec 31, 2021 | -4,630.00 |
| Sep 30, 2021 | -8,553.00 |
| Jun 30, 2021 | 17,859.00 |
| Mar 31, 2021 | 13,980.00 |